Fund Holdings — Enavate Sciences GP, LLC

Total Portfolio Value:
$345.38M
Total Bought:
$0
Total Sold:
$3.43M
Net Transaction:
-$3.43M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Sionna Therapeutics, Inc.(SION)2,478,0302,478,0300$99.34M$109.01M31.56%+$9.66M
Zenas BioPharma, Inc.(ZBIO)3,919,1593,919,1590$76.62M$99.47M28.80%+$22.85M
Immunome, Inc.(IMNM)3,613,7993,613,7990$79.03M$76.58M22.17%-$2.46M
BridgeBio Oncology Therapeutics, Inc.(BBOT)2,626,9462,626,9460$23.51M$20.02M5.80%-$3.49M
Compass Therapeutics, Inc.(CMPX)7,788,1507,788,1500$41.20M$17.06M4.94%-$24.14M
Upstream Bio, Inc.(UPB)2,459,7032,459,7030$22.14M$17.02M4.93%-$5.12M
CAMP4 THERAPEUTICS CORPORATION(CAMP)2,190,9201,425,541-765,379$9.66M$6.23M1.80%-$3.43M
Page 1 of 1
Enavate Sciences GP, LLC — 13F Holdings — Q2 2026 | TickerTrail